MoneyWorks4Me

Alembic Pharmaceuticals informs about annual report

15 Jun 2021 Evaluate

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that it has enclosed a copy of the Annual Report of the Company for the financial year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.




Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..